TITLE

Drugmaker Drama Ends Without Hitch: Perrigo Shareholders Rebuff Mylan Bid

AUTHOR(S)
AMY REEVES
PUB. DATE
November 2015
SOURCE
Investors Business Daily;11/13/2015, p00
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports that Perrigo Co. PLC's shareholders have opposed a hostile takeover bid by generic-drug manufacturer Mylan NV, resulting to the decline of Perrigo stock and an increase in Mylan stock. It reveals that Mylan stock posted a 12.9% increase while Perrigo stock has dropped by 6.2% to 146.90. Information about Mylan's focused approach to organic and inorganic growth is presented.
ACCESSION #
110919418

 

Related Articles

  • Perrigo rejects new Mylan bid. Investor's Business Daily // Investors Business Daily;4/30/2015, pA02 

    The article reports that drugstore supplier Perrigo Co. PLC has rejected the bid offered by American generic-drug maker Mylan NV following speculations that the bid would be bought by pharmaceutical company Teva Pharmaceutical Industries Ltd.

  • Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds. ED CARSON // Investors Business Daily;4/24/2015, p00 

    The article focuses on the decision of generic drugmaker Mylan to increase its offer for pharmaceutical company Perrigo. It states that Perrigo promptly rejected Mylan's bid, saying the takeover proposal was worse than before. In addition, Perrigo rejected Mylan's bid since its stocks has been...

  • Mylan Rejects 'Low Quality'. Investor's Business Daily // Investors Business Daily;4/28/2015, pA01 

    9 In rejecting a takeover bid from

  • Mylan Finally Over Perrigo? Investor's Business Daily // Investors Business Daily;11/16/2015, pA01 

    5

  • Mylan, Perrigo Face Off As Takeover Vote Nears. AMY REEVES // Investors Business Daily;11/12/2015, p00 

    The article offers information on the performance of stock prices and market share of generic drug makers including Mylan and Perrigo and mentions that both companies had won shareholders. According to Mylan executive chairman Robert Coury, the company had offered space to shareholders to share...

  • Mylan Bids $29 Bil For Perrigo. Investor's Business Daily // Investors Business Daily;4/13/2015, pB02 

    5 Officially unsolicited, the generic drugmaker Wed. offered $205 a share in cash and stock for pharma

  • Mylan. Investor's Business Daily // Investors Business Daily;7/30/2015, pA02 

    The article reports on the announcement of pharmaceutical firm Mylan NV that it has received approval from regulations in Europe to push through with its proposal to aquire healthcare supplier Perrigo Co. PLC.

  • Hostile And Hopeful Teva Offers $40 Bil For Mylan. AMY REEVES // Investors Business Daily;4/22/2015, pA01 

    The article focuses on the $40 billion bid of Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. to acquire its competitor Mylan NV, which also shows interest to buy generic drug maker Perrigo Co. LLC. The stand of Mylan on Teva's acquisition bid is discussed. Also explained is...

  • Abbott Affirms its Support for Mylan's proposed acquisition of Perrigo.  // eHEALTH;6/18/2015, p1 

    The article reports that global healthcare company Abbott has confirmed that it will continue support for pharmaceutical firm Mylan NV's growth strategy by stating its intent to support Mylan's proposed acquisition of pharmaceutical firm Perrigo. Topics include Abbott's intent to vote its 14.5...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics